Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
16.37
-0.30 (-1.77%)
At close: May 21, 2026, 4:00 PM EDT
16.37
+0.01 (0.03%)
After-hours: May 21, 2026, 4:41 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Alignment Healthcare stock has a consensus rating of "Strong Buy" and an average price target of $25.15. The average 1-year stock price forecast is 53.68% higher than the current stock price, while the lowest is $19 (+16.10%) and the highest is $30 (+83.32%).
Price Target: $25.15 (+53.68%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 12 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +34.43% | May 1, 2026 |
| Barclays | Barclays | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +16.10% | May 1, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $26 | Buy | Maintains | $23 → $26 | +58.88% | Feb 5, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +52.77% | Jan 16, 2026 |
| UBS | UBS | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | +28.32% | Jan 14, 2026 |
Financial Forecast
Revenue This Year
5.29B
from 3.95B
Increased by 34.04%
Revenue Next Year
6.80B
from 5.29B
Increased by 28.49%
EPS This Year
0.20
from -0.00
EPS Next Year
0.74
from 0.20
Increased by 279.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.5B | 8.8B | |||
| Avg | 5.3B | 6.8B | |||
| Low | 5.1B | 6.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 38.3% | 66.7% | |||
| Avg | 34.0% | 28.5% | |||
| Low | 28.3% | 17.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.25 | 0.85 | |
| Avg | 0.20 | 0.74 | |
| Low | 0.14 | 0.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 335.4% | |
| Avg | - | 279.9% | |
| Low | - | 231.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.